Umstead John V. - Insider Non-Derivative Transactions at G1 Therapeutics, Inc. (GTHX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 10, 2023, Umstead John V.'s relationship to G1 Therapeutics, Inc. (GTHX) is Officer (Chief Financial Officer), and currently has 93,886 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other GTHX insiders.
Data Source: SEC.
Umstead John V. - Insider Non-Derivative Transactions of GTHX Common Stock
Umstead John V. - Insider Non-Derivative Transactions at GTHX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 11, 2023 | Acquisition -- (Common Stock) | 35000 | 0 | 93886 |
| Mar 16, 2023 | Acquisition -- (Common Stock) | 50000 | 0 | 58886 |